Health Products

Quantum Blue Anti-Infliximab

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - General hospital and personal use
Product: Quantum Blue Anti-Infliximab
Issue: Medical devices - Inaccurate test or measurement results
What to do: Contact the manufacturer if you require additional information.
Audience: General public, Health professionals, Hospitals
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Affected ProductsLot or Serial NumberModel or catalog number
Quantum Blue Anti-Infliximab1107.NLF-ADIF25

Issue

Positive, instead of negative, results have been reported by customers for the low control and patient samples for Quantum Blue® Anti-Infliximab production Series 1107. The increased false-positive rate was confirmed internally at Bühlmann. Approximately 80% of low control results and 24% of negative patients' samples are now expected to be false positive.

Recall start date: Jan 17, 2022

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime